Effects of tumor-infiltrating lymphocytes on nonresponse rate of neoadjuvant chemotherapy in patients with invasive breast cancer.
Autorzy:
Qian XL; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China. Xia XQ; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China. Li YQ; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China. JiaYM; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China. Sun YY; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China. Song YM; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China. Xue HQ; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China. Hao YF; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China. Wang J; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China. Wang XZ; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China. Liu CY; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China. Zhang XM; Department of Pathology, Cooper Medical School of Rowan University, Camden, NJ, USA. Zhang LN; The Second Surgical Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, Tianjin, 300060, China. Guo XJ; Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, National Human Genetic Resource Sharing Service Platform, West Huanhu Road, Tianjin, 300060, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jun 07; Vol. 13 (1), pp. 9256. Date of Electronic Publication: 2023 Jun 07.
Preoperative CA19-9 and GGT ratio as a prognostic indicator in ampullary carcinoma.
Autorzy:
Chen RQ; Department of Hepatobiliary Surgery, The Fourth Affiliated Hospital of Hebei Medical University, Hebei, China. Zhang ZL; Department of Hepatobiliary Surgery, The Fourth Affiliated Hospital of Hebei Medical University, Hebei, China. JiaYM; Department of Hepatobiliary Surgery, The Fourth Affiliated Hospital of Hebei Medical University, Hebei, China. Chen RX; Jianhua Campus, Hebei Medical University, shijiazhuang, China. Peng L; Department of Hepatobiliary Surgery, The Fourth Affiliated Hospital of Hebei Medical University, Hebei, China. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2023 Mar 13; Vol. 23 (1), pp. 72. Date of Electronic Publication: 2023 Mar 13.
Synthesis of Pyrrolidine Monocyclic Analogues of Pochonicine and Its Stereoisomers: Pursuit ofSimplified Structures and Potent β- N -Acetylhexosaminidase Inhibition.
Autorzy:
Yan X; Beijing National Laboratory for Molecular Science (BNLMS), CAS Key Laboratory of Molecular Recognition and Function, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.; University of Chinese Academy of Sciences, Beijing 100049, China. Shimadate Y; Department of Hospital Pharmacy, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. Kato A; Department of Hospital Pharmacy, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. Li YX; Beijing National Laboratory for Molecular Science (BNLMS), CAS Key Laboratory of Molecular Recognition and Function, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.; University of Chinese Academy of Sciences, Beijing 100049, China. JiaYM; Beijing National Laboratory for Molecular Science (BNLMS), CAS Key Laboratory of Molecular Recognition and Function, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.; University of Chinese Academy of Sciences, Beijing 100049, China. Fleet GWJ; Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Mansfield Road, Oxford OX13TA, UK.; National Engineering Research Center for Carbohydrate Synthesis, Jiangxi Normal University, Nanchang 330022, China. Yu CY; Beijing National Laboratory for Molecular Science (BNLMS), CAS Key Laboratory of Molecular Recognition and Function, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.; University of Chinese Academy of Sciences, Beijing 100049, China.; National Engineering Research Center for Carbohydrate Synthesis, Jiangxi Normal University, Nanchang 330022, China.
Apatinib-induced Grade 3 hand-foot syndrome in advanced lung adenocarcinoma successful treated with thalidomide: A case report.
Autorzy:
Ren Y; Department of Oncology, North Sichuan Medical College, Nanchong, Sichuan, China. Li T; Department of Oncology, The Second People's Hospital of Yibin, Yibin, Sichuan, China. Du LY; Department of Oncology, The Second People's Hospital of Yibin, Yibin, Sichuan, China. Qiu Y; Department of Oncology, The Second People's Hospital of Yibin, Yibin, Sichuan, China. Wang SB; Department of Oncology, The Second People's Hospital of Yibin, Yibin, Sichuan, China. Lei KJ; Department of Oncology, The Second People's Hospital of Yibin, Yibin, Sichuan, China. JiaYM; Department of Oncology, The Second People's Hospital of Yibin, Yibin, Sichuan, China.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2020 Mar; Vol. 33 (2), pp. e13241. Date of Electronic Publication: 2020 Feb 11.
The volume of Tc sulfur colloid SPET-defined active bone marrow can predict grade 3 or higher acute hematologic toxicity in locally advanced cervical cancer patients who receive chemoradiotherapy.
Autorzy:
Wang SB; Department of Oncology, The Second People's Hospital of Yibin City, Yibin, Sichuan, China. Liu JP; Department of Laboratory Medicine, The Second People's Hospital of Yibin City, Yibin, Sichuan, China. Lei KJ; Department of Oncology, The Second People's Hospital of Yibin City, Yibin, Sichuan, China. JiaYM; Department of Oncology, The Second People's Hospital of Yibin City, Yibin, Sichuan, China. Xu Y; Department of Oncology, The Second People's Hospital of Yibin City, Yibin, Sichuan, China. Rong JF; Department of Oncology, The Second People's Hospital of Yibin City, Yibin, Sichuan, China. Wang CX; Department of Oncology, The Second People's Hospital of Yibin City, Yibin, Sichuan, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2019 Dec; Vol. 8 (17), pp. 7219-7226. Date of Electronic Publication: 2019 Oct 16.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
Synthesis and Glycosidase Inhibition of Broussonetine M and Its Analogues.
Autorzy:
Wu QK; Beijing National Laboratory for Molecular Science (BNLMS), CAS Key Laboratory of Molecular Recognition and Function, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China. .; University of Chinese Academy of Sciences, Beijing 100049, China. . Kinami K; Department of Hospital Pharmacy, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. . Kato A; Department of Hospital Pharmacy, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. . Li YX; Beijing National Laboratory for Molecular Science (BNLMS), CAS Key Laboratory of Molecular Recognition and Function, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China. .; University of Chinese Academy of Sciences, Beijing 100049, China. . Fleet GWJ; Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Mansfield Road, OX13TA Oxford, UK. .; National Engineering Research Center for Carbohydrate Synthesis, Jiangxi Normal University, Nanchang 330022, China. . Yu CY; Beijing National Laboratory for Molecular Science (BNLMS), CAS Key Laboratory of Molecular Recognition and Function, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China. .; University of Chinese Academy of Sciences, Beijing 100049, China. .; National Engineering Research Center for Carbohydrate Synthesis, Jiangxi Normal University, Nanchang 330022, China. . JiaYM; Beijing National Laboratory for Molecular Science (BNLMS), CAS Key Laboratory of Molecular Recognition and Function, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China. .; University of Chinese Academy of Sciences, Beijing 100049, China. .
Enhanced responsiveness of platelets to vicagrel in IL-10-deficient mice through STAT3-dependent up-regulation of the hydrolase arylacetamide deacetylase in the intestine.
Autorzy:
JiaYM; General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.; Department of Pharmacology, College of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China. Zhou H; General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.; Department of Pharmacology, College of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China. Tai T; General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Gu TT; General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Ji JZ; General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Mi QY; General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Huang BB; General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Li YF; General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Zhu T; General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.; Department of Pharmacology, College of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China. Xie HG; General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.; Department of Pharmacology, College of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.; Department of Clinical Pharmacy, Nanjing Medical University School of Pharmacy, Nanjing, China.
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2019 Jun; Vol. 176 (11), pp. 1717-1727. Date of Electronic Publication: 2019 Apr 21.
Identification of hub genes associated with postmenopausal osteoporosis by Gibbs sampling method.
Autorzy:
Zhang YP; Department of Orthopedics, Chifeng Municipal Hospital, Chifeng, Inner Mongolia 024000, P.R. China. Ao S; Department of Orthopedics, Chifeng Municipal Hospital, Chifeng, Inner Mongolia 024000, P.R. China. Liu Y; Department of Orthopedics, Chifeng Municipal Hospital, Chifeng, Inner Mongolia 024000, P.R. China. Wang Y; Department of Orthopedics, Chifeng Municipal Hospital, Chifeng, Inner Mongolia 024000, P.R. China. JiaYM; Department of Orthopedics, Chifeng Municipal Hospital, Chifeng, Inner Mongolia 024000, P.R. China. Zhang H; Department of Orthopedics, Chifeng Municipal Hospital, Chifeng, Inner Mongolia 024000, P.R. China. Leng H; Department of Orthopedics, Chifeng Municipal Hospital, Chifeng, Inner Mongolia 024000, P.R. China.
Genetic polymorphisms in CDH1 are associated with endometrial carcinoma susceptibility among Chinese Han women.
Autorzy:
Geng YH; Department of Pathology, School of Basic Medical Science, Peking University Health Science Center, Beijing 100191, P.R. China. Wang ZF; Department of Pathology, School of Basic Medical Science, Peking University Health Science Center, Beijing 100191, P.R. China. JiaYM; Department of Pathology, School of Basic Medical Science, Peking University Health Science Center, Beijing 100191, P.R. China. Zheng LY; Department of Pathology, School of Basic Medical Science, Peking University Health Science Center, Beijing 100191, P.R. China. Chen L; Department of Pathology, Beijing Hospital, Beijing 100005, P.R. China. Liu DG; Department of Pathology, Beijing Hospital, Beijing 100005, P.R. China. Li XH; Department of Pathology, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing 100142, P.R. China. Tian XX; Department of Pathology, School of Basic Medical Science, Peking University Health Science Center, Beijing 100191, P.R. China. Fang WG; Department of Pathology, School of Basic Medical Science, Peking University Health Science Center, Beijing 100191, P.R. China.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2018 Nov; Vol. 16 (5), pp. 6868-6878. Date of Electronic Publication: 2018 Sep 20.
Diffuse Myocardial Injuries are Present in Subclinical Hypothyroidism: A Clinical Study Using Myocardial T1-mapping Quantification.
Autorzy:
Yao Z; Department of Endocrinology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China. Gao X; Department of Endocrinology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China. Liu M; Department of Radiology, China-Japan Friendship Hospital, Beijing, 100029, China. Chen Z; Department of Endocrinology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China. Yang N; Department of Endocrinology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China. JiaYM; Department of Endocrinology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China. Feng XM; Department of Endocrinology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China. Xu Y; Department of Endocrinology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China. Yang XC; Heart Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China. . Wang G; Department of Endocrinology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2018 Mar 22; Vol. 8 (1), pp. 4999. Date of Electronic Publication: 2018 Mar 22.
Typ publikacji:
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
Combined effect of I and gemcitabine on PANC-1 cells: Cellular apoptosis and cell cycle arrest.
Autorzy:
Li D; Department of Interventional Medicine, The Second Hospital of Shandong University, Jinan, China. JiaYM; Department of Interventional Medicine, Linzi District People's Hospital, Jinan, China. Cao PK; Department of Interventional Medicine, The Second Hospital of Shandong University, Jinan, China. Wang W; Department of Interventional Medicine, The Second Hospital of Shandong University, Jinan, China. Liu B; Department of Interventional Medicine, The Second Hospital of Shandong University, Jinan, China. Li YL; Department of Interventional Medicine, The Second Hospital of Shandong University, Jinan, China.
Genetic Polymorphisms of TGFB1, TGFBR1, SNAI1 and TWIST1 Are Associated with Endometrial Cancer Susceptibility in Chinese Han Women.
Autorzy:
Yang L; Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing, China.; Department of Pathology, Peking University Third Hospital, Beijing, China. Wang YJ; Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing, China.; Department of Pathology, Peking University Third Hospital, Beijing, China. Zheng LY; Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing, China. JiaYM; Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing, China.; Department of Pathology, Peking University Third Hospital, Beijing, China. Chen YL; Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing, China.; Department of Pathology, Peking University Third Hospital, Beijing, China. Chen L; Department of Pathology, Beijing Hospital, Beijing, China. Liu DG; Department of Pathology, Beijing Hospital, Beijing, China. Li XH; Department of Pathology, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China. Guo HY; Department of Gynecology, Peking University Third Hospital, Beijing, China. Sun YL; Key Laboratory of Genomic and Precision Medicine, Chinese Academy of Sciences, Beijing, China. Tian XX; Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing, China.; Department of Pathology, Peking University Third Hospital, Beijing, China. Fang WG; Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing, China.; Department of Pathology, Peking University Third Hospital, Beijing, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2016 May 12; Vol. 11 (5), pp. e0155270. Date of Electronic Publication: 2016 May 12 (Print Publication: 2016).
Effects of the microcrack shape, size and direction on the poroelastic behaviors of a single osteon: a finite element study.
Autorzy:
Cen HP; Shanxi Key Laboratory of Material Strength & Structural Impact, and College of Mechanics, Taiyuan University of Technology, Taiyuan 030024, P.R. China. Wu XG; Shanxi Key Laboratory of Material Strength & Structural Impact, and College of Mechanics, Taiyuan University of Technology, Taiyuan 030024, P.R. China. Yu WL; Shanxi Key Laboratory of Material Strength & Structural Impact, and College of Mechanics, Taiyuan University of Technology, Taiyuan 030024, P.R. China. Liu QZ; College of Mechanical Engineering, Taiyuan University of Technology, Taiyuan 030024, P.R. China. JiaYM; Shanxi Key Laboratory of Material Strength & Structural Impact, and College of Mechanics, Taiyuan University of Technology, Taiyuan 030024, P.R. China.
Association of Genetic Polymorphisms in CDH1 and CTNNB1 with Breast Cancer Susceptibility and Patients' Prognosis among Chinese Han Women.
Autorzy:
JiaYM; Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China; Department of Pathology, Peking University Third Hospital, Beijing, China. Xie YT; Breast Center, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China. Wang YJ; Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China; Department of Pathology, Peking University Third Hospital, Beijing, China. Han JY; Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China; Department of Pathology, Peking University Third Hospital, Beijing, China. Tian XX; Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China; Department of Pathology, Peking University Third Hospital, Beijing, China. Fang WG; Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China; Department of Pathology, Peking University Third Hospital, Beijing, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Aug 18; Vol. 10 (8), pp. e0135865. Date of Electronic Publication: 2015 Aug 18 (Print Publication: 2015).
Eyelash trichomegaly following treatment with erlotinib in a non-small cell lung cancer patient: A case report and literature review.
Autorzy:
Wang SB; Department of Oncology, The Second People's Hospital of Yibin, Yibin, Sichuan 644000, P.R. China. Lei KJ; Department of Oncology, The Second People's Hospital of Yibin, Yibin, Sichuan 644000, P.R. China. Liu JP; Department of Laboratory Medicine, The Second People's Hospital of Yibin, Yibin, Sichuan 644000, P.R. China. JiaYM; Department of Oncology, The Second People's Hospital of Yibin, Yibin, Sichuan 644000, P.R. China.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2015 Aug; Vol. 10 (2), pp. 954-956. Date of Electronic Publication: 2015 May 26.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
